03580nam a22003855i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001200153072001600165072002300181072001500204100007900219245013000298250001800428264006900446300003500515336002600550337002600576338003600602347002400638505165500662520062502317650001902942650001902961710003402980773002603014776003603040776003603076776003603112856004603148978-3-031-58557-9DE-He21320251030112619.0cr nn 008mamaa240709s2024    sz |    s    |||| 0|eng d  a97830315855797 a10.1007/978-3-031-58557-92doi 4aRE1-994 7aMJQ2bicssc 7aMED0630002bisacsh 7aMJQ2thema1 aWeiss, Jeffrey N.eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aOcular Stem Cell Studiesh[electronic resource] :bA Comprehensive Overview of Global Clinical Trials /cby Jeffrey N. Weiss.  a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aXIII, 359 p.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aSection 1: Active/Recruiting Studies -- Section 1, Part 1: Retina/Optic Nerve -- Chapter 1: United States -- Chapter 2: Belarus -- Chapter 3: Caribbean/Latin America -- Chapter 4: China -- Chapter 5: Great Britain -- Chapter 6: Indonesia -- Chapter 7: Japan -- Chapter 9: Turkey -- Section 1, Part 2: Anterior Segment -- Chapter 10: United States -- Chapter 11: Canada -- Chapter 12: China -- Chapter 13: France -- Chapter 14: Spain -- Section 2: Active, Non-recruiting Studies -- Section 2, Part 1: Retina/Optic Nerve -- Chapter 15: United States -- Chapter 16: No Location -- Section 2, Part 2: Anterior Segment -- Chapter 17: United States -- Chapter 18: Germany -- Chapter 19: Denmark -- Chapter 20: France -- Chapter 21: Spain -- Section 3: Completed Studies -- Section 3, Part 1: Retina/Optic Nerve -- Chapter 22: United States -- Chapter 23: Brazil -- Chapter 24: Turkey -- Section 3, Part 2: Anterior Segment -- Chapter 25: United States -- Chapter 26: Belarus -- Chapter 27: Iran -- Chapter 28: Korea -- Chapter 29: Spain -- Section 4: Unknown Status -- Chapter 30: Belgium -- Chapter 31: Brazil -- Chapter 32: China -- Chapter 33: Egypt -- Chapter 34: India -- Chapter 35: Jordan -- Chapter 36: Korea -- Chapter 37: Lebanon -- Chapter 38: Malaysia -- Chapter 39: Poland -- Chapter 40: Spain -- Chapter 41: Taiwan -- Chapter 42: Thailand -- Section 5: Withdrawn Studies -- Chapter 43: United States -- Chapter 44: China -- Section 6: Terminated Studies -- Chapter 45: United States -- Chapter 46: Iran -- Section 7: Suspended Studies -- Chapter 47: Singapore -- Section 8: Analysis -- Chapter 48: Analysis of studies -- Chapter 49: Comments.  aThis book is a compendium of the worldwide ocular stem cell studies registered with clinicaltrials.gov. The study title is provided, along with the country of origin and the clinical trial number in order to make it easier for the reader to locate the study and obtain further information. An analysis of the type of stem cell utilized and study support is also provided. The final section deals with issues encountered by the stem cell researchers. Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers. 0aOphthalmology.14aOphthalmology.2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303158556208iPrinted edition:z978303158558608iPrinted edition:z978303158559340uhttps://doi.org/10.1007/978-3-031-58557-9